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Abstract The low percentages of naïve T cells com-
monly observed in elderly people are thought to be
causally associated with mortality, primarily from infec-
tious disease, and are taken as a hallmark of “immuno-
senescence”. Whether low levels of naive cells actually
do associate with mortality has, however, not been
tested in longitudinal studies. Here, we present correla-
tions between peripheral T-cell phenotypes and 8-year
survival in individuals from the population-based
prospective Leiden 85-plus Study. Counter-intuitively,
we found that a lower frequency of naïve CD8+ T cells
(characterized as CD45RA+CCR7+CD27+CD28+) at
baseline (>88 years) correlated with significantly better
survival, while there was a tendency for the reciprocal
accumulation of late-differentiated effector memory
cells (CD45RA−CCR7−CD27−CD28−) also to associ-
ate with better survival. These findings suggest that
better retention of memory cells specific for previously
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encountered antigens may provide a survival advantage
in this particular population. Given the prevalence of
Cytomegalovirus (CMV) and its reported association
with immunosenescence, we tested whether memory
for this potential pathogen was relevant to survival.
We found that individuals mounting an exclusively
pro-inflammatory ex vivo response (TNF, IFN-γ, IL-
17) to the major CMV target molecules pp65 and IE1
had a significant survival advantage over those also
having anti-inflammatory responses (IL-10). These
findings suggest that higher levels of naïve T cells may
not necessarily be associated with a survival advantage
and imply that the nature of immunosurveillance against
CMVmay be crucial for remaining longevity, at least in
the very elderly.
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Abbreviations
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Introduction
Alterations to the cellular composition and function of
the immune system occurring as individuals age are
generally perceived as detrimental, and reflect a state
commonly termed immunosenescence (Gruver et al.
2007). However, there is an alternative school of
thought suggesting that the age-associated differences
observed are adaptational, and indicate a remodeling of
immunity depending on previous exposures and antici-
pated future exposures (Franceschi et al. 1995). A re-
duced frequency and number of peripheral naïve T cells
and reciprocal accumulation of late-differentiated mem-
ory T cells are commonly accepted as hallmark charac-
teristics of immunosenescence. These changes are
believed to contribute to or even be responsible for the
significantly higher incidence and severity of infectious
disease as well as possibly cancer and autoimmune
diseases and the decreased response to vaccination in
the elderly (McElhaney and Effros 2009; Malaguarnera
et al. 2010). Poor proliferative responses of T cells to
mitogens have been associated with mortality in people
of different age groups in several studies over the years
(Murasko 1988; Wayne et al. 1990), suggesting a link
between a simple measure of functional integrity of T-
cell immunity and mortality. Due to the logistical con-
straints of investigating a long-lived species, most of the
more sophisticated assessments of the differences in
immunity between young and old have been based on
cross-sectional studies, and so cannot formally demon-
strate age-associated changes and their relationships to
health measures.
One notable exception to this are the Swedish
OCTO longitudinal studies performed over the last
two decades in free-living individuals over 85 years
of age. These investigations resulted in the emerging
concept of an “immune risk profile” (IRP2), a cluster
of slightly more sophisticated parameters, but also still
including T-cell proliferation to mitogens, which was
associated with 2-, 4-, and 6-year mortality on follow-
up (Derhovanessian et al. 2009). In its original form,
individuals in the IRP group (ca. 15 % of the popula-
tion at baseline) were characterized by an inverted
CD4/CD8 ratio (<1), increased absolute numbers of
CD8+CD28− T cells per microliter of blood, poor
mitogen-induced T-cell proliferative responses, low
frequencies of B cells, and, initially surprisingly, sero-
positivity for Cytomegalovirus (CMV, the common
persistent β-herpes virus HHV5) (Ferguson et al.
1995; Wikby et al. 1998; Olsson et al. 2000). We
and others have shown that persistent infection with
this virus is associated with accumulation of late-stage
differentiated CD8+ T cells (Almanzar et al. 2005;
Chidrawar et al. 2009; Derhovanessian et al. 2010).
This has led to the increasingly accepted notion that
CMV is one of or even the main driving force causing
changes to immune signatures associated with immu-
nosenescence (Pawelec and Derhovanessian 2011).
Nonetheless, the longitudinal data from the OCTO
studies came from people over 85 years of age selected
for very good health at baseline, and although the pres-
ence of the IRP has been confirmed in the NONA
studies of a representative population not in excellent
health (Wikby et al. 2002), it was still limited to the
inhabitants of one small southern Swedish city. Hence,
its general applicability, even only to those over 85 years
of age, has never been assessed.
In an effort to investigate this issue, here we have
performed a detailed study using more sophisticated
immunological analysis on a subgroup of individuals
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participating in the Leiden 85-plus Study, a prospective
population-based cohort study of individuals at the age of
85 years living in Leiden, the Netherlands (van der Wiel
et al. 2002). The cell samples studied here were from
individuals 3 years after the original recruitment at base-
line, i.e., at the age of 88 years, and with a prospective 8-
year mortality data follow-up. Our findings reveal a set of
immune parameters associating with 8-year mortality,
but these are different from those identified for the IRP,
and reveal an unexpected inverse relationship between
the percentage of naive CD8+ Tcells and survival. Thus,
the widely accepted assumption that a more late-
differentiated T-cell compartment, characterized by low-
er frequency of naïve cells and accumulated late-
differentiated “senescent” cells, is always detrimental to
survival may not necessarily be true, at least in the very
elderly. Rather, as documented here, the presence of
larger proportions of late-differentiated effector memory
and effector cells, able to mount robust unopposed pro-
inflammatory responses to major CMVantigens, is pos-
itively associated with longer survival in this population.
Materials and methods
Subjects
A subgroup of 50 participants of the Leiden 85-plus
Study, a population-based, prospective study of inhab-
itants of Leiden, the Netherlands were analyzed here.
The details of the Leiden 85-plus Study have been
published previously (van der Wiel et al. 2002).
Briefly, all inhabitants of Leiden born between 1912
and 1914 were invited to participate in the study
between September 1997 and 1999. All participants
were visited at their place of residence by medical staff
and nurses. The Medical Ethics Committee of the
Leiden University Medical Center approved the study,
and informed consent was obtained from all partici-
pants. The blood samples analyzed in this study were
taken in 2002. The characteristics of the 50 individuals
studied here are listed in Table 1. All subjects were
followed up for survival until January 2010 with a
follow-up period of 8 years. Date and cause of death
data were obtained from the Dutch civic registry.
Anti-CMV IgG titers were measured in plasma using
a CMV IgG kit (ETI-CYTOK-G PLUS DiaSorin,
Saluggia, Italy) based on enzyme immunoassay
technology.
Potential confounders
Global cognitive performance was assessed with the
Mini-Mental State Examination (MMSE3) (Folstein et
al. 1975). The 15-item Geriatric Depression Scale
(GDS-154) was used to measure depressive symptoms
(Yesavage et al. 1982). Because of the limited validity of
the GDS-15 in people with moderate and severe cogni-
tive impairment, this was completed only by people
withMMSE scores of more than 18. Ability to complete
daily activities of living was measured by the Groningen
Activity Restriction Scale (GARS) (Kempen et al.
1996). It assesses competence in abilities in nine per-
sonal basic activities of daily living (ADL) and nine
instrumental activities of daily living (IADL). A
summed score was calculated for basic IADL ranging
from 9 (indicating ability to perform all activities with-
out assistance or undue effort) to 36 (indicating disabil-
ity). Other variables were gender and CMV serostatus.
Flow cytometry analysis
After thawing, cryopreserved PBMCs were treated with
human immunoglobulin, GAMUNEX (Bayer,
Leverkusen, Germany), and ethidium monoazide
(EMA) (Invitrogen, Karlsruhe, Germany) to block Fc
receptors and label nonviable cells. Cells were then
stained indirectly with anti-KLRG-1 primary antibody
(Ab) (kindly provided by Prof. Hans-Peter Pircher,
Freiburg, Germany) followed by staining with Pacific
Orange-conjugated goat anti-mouse IgG (Invitrogen).
After blocking with mouse serum (Chemicon/Millipore,
Schwalbach, Germany), directly conjugated mAbs,
CD3-PE (Calltag; Invitrogen), CD4-PerCP, CD8-
allophycocyanin-Cy7, CCR7-PE-Cy7 (BD Biosciences,
Heidelberg, Germany), CD27-allophycocyanin,




Female, n (%) 5 (55.5) 33 (80.5)
White blood cells (×109/l) 5.75 (1.3) 6.8 (1.8)
MMSE total score 27 (6.5) 25 (9.5)
GARS total score 46 (16.5) 37 (19.5)
GDS total score 4 (6.0) 1 (2.0)*
* Data from 31 individuals
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CD45RA-Pacific Blue, CD28-Alexa Fluor 700
(BioLegend, San Diego, CA), and CD57-FITC
(Immunotools, Freiburg, Germany) were added. After
20 min of incubation on ice, cells were washed and
analyzed immediately on an LSR II cytometer with
FACSDiva software (BD Biosciences). The spectral
overlap between all channels was calculated automatical-
ly by the BD FACSDiva software, after measuring neg-
ative and single-color controls. Data were analyzed using
FlowJo software (Tree Star, Portland, OR, USA). For
data analysis, EMA-positive dead cells were excluded.
In the viable gate, lymphocytes were gated in a forward
light scatter versus side scatter dot blot according to their
size and granularity. T cells within the lymphocyte gate
were characterized as CD3+ cells. T-cell subsets were
characterized according to surface expression of
CD45RA, CCR7, CD27, and CD28 as described previ-
ously (Derhovanessian et al. 2010). Flow cytometry
staining and data analysis were performed on blinded
samples.
Responsiveness to CMV antigens
PBMCs were thawed and allowed to rest for 8 h in X-
Vivo15 medium (Cambrex) at 1×106/ml at 37°C. pp65
and IE-1 PepMixes (JPT Technologies, Berlin,
Germany) containing a mixture of short peptides cover-
ing the whole sequence of the molecules were used as
antigens at a concentration of 1 μg/ml as recommended
by the manufacturer. Peptides were added together with
1 μl/ml Golgi-Plug (BD Biosciences) to the cultures for
16 h. Medium alone and 50 ng/ml PMA (Sigma Aldrich,
Munich, Germany) together with 750 ng/ml Ionomycin
(Merck, Darmstadt, Germany) were used as negative and
positive controls, respectively. The cells were then har-
vested, washed, and stained first indirectly for CD3
[OKT3 primary and Pacific orange-conjugated goat
anti-mouse IgG secondary antibody (Invitrogen)]. After
blocking with mouse serum (Chemicon/Millipore), the
cells were stained with CD4-PerCP and CD8-APC-Cy7
(BD, Biosciences) mAbs. Following fixation and perme-
abilization using the BDCytofix-Cytoperm solution (BD
Biosciences), the cells were stained with IFNγ-PE-Cy7
(BDBiosciences), TNF-FITC (Miltenyi Biotec, Bergisch
Gladbach, Germany), IL-17-PerCP-Cy5.5, and IL-10-
Pacific Blue (eBioscience, Frankfurt, Germany). EMA
was used to exclude dead cells. Samples were measured
directly using the BD-LSR-II as described in the previous
section. Cytokine secretion was only considered peptide
specific when the amount of cytokine produced in re-
sponse to a PepMix was at least twofold higher than the
amount of cytokine produced in medium alone. These
experiments could be performed in 21CMV-seropositive
individuals.
Statistical analyses
Two independent groups were compared using the
Mann–Whitney U test. Survival analysis was performed
using the Cox regression analysis and adjustment of the
hazard ratios (HR) of mortality for potential confounders,
including gender, CMV serostatus, and markers of frailty
(GARS, MMSE, and GDS). We applied Kaplan–Meier
curves to display survival according to responsiveness to
CMVantigens. Correlations between different T-cell sub-
sets were analyzed using Spearman’s correlation analysis.
All analyses were performed by Graph Pad Prism v3 or
SPSS for Windows (SPSS Inc., Chicago, USA), version
17. p values <0.05 were considered significant.
Results
CMV and the distribution of T-cell subsets in the very
elderly
Considering its marked effect on the distribution of
different T-cell subsets, particularly in the CD8 compart-
ment and its inclusion as one of the parameters of the
IRP, we first determined the impact of CMV infection in
our cohort of individuals over the age of 88 years at
baseline. Characteristics of the individuals grouped
according to CMV serostatus are given in Table 1.
Frequencies of different naïve and memory T-cell sub-
sets were analyzed using 10-color flow cytometry, and
different subsets were compared between CMV-
seropositive and -seronegative individuals. As seen in
other studies of different populations, we observed a
strong association of CMV seropositivity with the distri-
bution of different T-cell phenotypes; within the CD8
compartment, on average, there was a markedly lower
percentage of naïve cells (N, defined as CD45RA
+CCR7+CD27+CD28+, p00.03) and a reciprocal accu-
mulation of late-differentiated effector memory (EM35,
CD45RA−CCR7−CD27−CD28−, p00.02) and late-
differentiated effector (E6, CD45RA+CCR7−CD27
−CD28−, p00.02) populations (Fig. 1a). Within CD4 T
cells, there was a trend towards lower levels of naïve T
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cells in CMV-seropositive individuals, but this did not
reach statistical significance (Fig. 1b, left-hand panel,
p00.15). However, CMV infection was associated with
accumulations of late-differentiated effector memory
(EM3) T cells (p<0.001), even up to 70 % of all periph-
eral CD4+ cells in one individual (Fig. 1b, middle panel).
We also observed the emergence of a small population of
late-differentiated CD4+ effector cells, re-expressing
CD45RA in CMV-seropositive individuals, which was
absent in most of the CMV-seronegative donors (Fig. 1b,
right-hand panel). Additionally, we determined the T-cell
differentiation status at the individual donor level by
calculating the ratio of late-differentiated effector mem-
ory and effector subsets divided by the frequency of
Fig. 1 CMV seropositivity and distribution of T-cell pheno-
types. Frequency of naïve and late-differentiated memory T cells
within CD8+ (a) and CD4+ T cells (b) in seven CMV-
seronegative (CMV−) and 41 CMV-seropositive (CMV+)
individuals. Frequency of T cells carrying putative senescence
markers CD57+ (c) and KLRG-1 (d) on CD4+ and CD8+ T
cells were compared in the same individuals. Horizontal bars
represent the median of each group
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naïve T cells for each person. CMV-seronegative indi-
viduals had a median “differentiation index” of 0.03
(IQR 0.007–0.15) and 2.88 (IQR 0.7–9) for CD4+ and
CD8+ T cells, respectively. In contrast, in CMV-
seropositive individuals, the differentiation index for
CD4+ (0.77, IQR 0.15–1.59) and CD8+ T cells (23.92,
IQR 9.5–54.9) was significantly higher (p00.002 and
p00.003, respectively). Consistent with this, there was a
marked accumulation of CD4+ and CD8+ T cells carry-
ing the putative very late differentiation or “senescence”
markers CD57 and KLRG1 in CMV-seropositive indi-
viduals (Fig. 1c, d).
Lower frequency of naïve CD8+ T cells is associated
with better survival
Next we sought to determine if the large inter-
individual variability seen for the T cell phenotypes,
particularly in CMV-seropositive individuals, had any
impact on 8-year survival in this very elderly cohort.
Cox regression analysis was performed to calculate
hazard ratios for the study population (Table 2). This
revealed a significant inverse correlation between the
percentage of naïve CD8+ T cells and survival, even
after adjusting for gender, CMV serostatus, and frailty
markers. Other T-cell phenotypes did not correlate
with survival (Table 2). In order to further characterize
the individuals with low naïve T-cell frequencies, a
correlation analysis between this population and dif-
ferent memory cell phenotypes within both CD4+ and
CD8+ T cells was performed. A low percentage of
CD8+ naïve cells significantly correlated with a higher
frequency of total CD8+ cells and the EM3 phenotype
(Table 3). Although no direct correlation between
naïve CD8+ T cells and the E phenotype was observed
(p00.07, Table 3), individuals with lower frequency of
naïve T cells did harbor higher frequency of both EM3
and E cells (Table 3).
In vitro pro-inflammatory response against CMV
antigens in the absence of an anti-inflammatory
response correlates with better survival
Because subjects with lower percentages of naïve Tcells
possess higher levels of late-differentiated memory pop-
ulations, we hypothesized that the survival advantage
for individuals with few naïve cells might be correlated
with a higher functional capacity for responses against
previously encountered infectious agents. Because the
majority of individuals in our study were CMV sero-
positive, we used CMV antigens as a model to assess
this; we analyzed the ex vivo cytokine response of CMV-
seropositive individuals against pools of overlapping
peptides encompassing pp65 and IE1, two immunodo-
minant CMV T-cell antigens. Responses against one or
both antigens could be detected in 18/21 (85.7%) CMV-
seropositive individuals. In the majority of responding
individuals (15/18), immune responses against both
antigens could be detected. One individual responded
only to IE1 and two only against pp65. The main re-
sponse against both antigens was of a pro-inflammatory
type (IFNγ and/or TNF); however, some individuals
also responded with an anti-inflammatory cytokine pro-
file in addition (IL-10 produced by either or both CD4+
and CD8+ T cells). Representative FACS plots of one
donor with a strong pro-inflammatory response against
IE-1 and IL-10 response against pp65 are shown in
Fig. 2. Th17 responses against pp65 and IE1 were
detected in eight and three individuals, respectively.
Responders were grouped according to their cytokine
profile: those with only pro-inflammatory responses
(producing either or all of IFNγ, TNF, or IL-17) and
those who also had an anti-inflammatory response (pro-
ducing IL-10 as well) against any of the antigens. There
was a significant survival disadvantage if an anti-
inflammatory response against one or both of the anti-
gens was induced in addition to the pro-inflammatory
response (Fig. 3a). The difference remained significant
after adjusting for gender and frailty markers (Table 4).
Next, we sought to determine if an immune response
against a certain antigen was associated with survival.
For pp65, there was a significant survival advantage for
individuals capable of mounting a pro-inflammatory
response in the absence of an IL-10 response (Fig. 3b).
A similar trend was observed for IE1, but this did not
reach statistical significance (Fig. 3c). After adjusting
for gender and frailty markers, we observed a significant
correlation between the type of response mounted
against both antigens and survival (Table 4).
Discussion
In this study, we present data demonstrating for the first
time that the frequency of CD8+ naïve Tcells (defined as
CD45RA+CCR7+CD27+CD28+) at baseline inversely
correlates with 8-year survival in individuals in the
Leiden 85+ study over 88 years of age at the time of
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blood sampling, contrary to initial expectations. This was
unanticipated because decreased levels of naïve T cells,
one of the hallmark features of immunosenescence com-
monly observed in the elderly, has often been postulated
to be the reason for increased mortality from infectious
disease in this age group. Nonetheless, these data are
consistent with earlier work from the Swedish OCTO/
NONA longitudinal studies, in individuals over the age
of 85 years, where the number of naïve T cells had not
been part of a cluster of immune parameters correlating
Table 3 Correlation analysis
between the frequency of CD8+
naïve cells (CD45RA+CCR7
+CD27+CD28+) and different
CD8 differentiation stages in 50
individuals
Parameter Spearman r 95 % CI p value
CD8+/CD3+ −0.3794 −0.6004 to −0.1045 0.006
CD45RA−CCR7−CD27−CD28−/CD8 (EM3) −0.5084 −0.6937 to −0.2601 <0.001
CD45RA+CCR7−CD27−CD28−)/CD8 (E) −0.2531 −0.5029 to 0.03565 0.076
EM3+E −0.52 −0.7046 to −0.2799 <0.001
Table 2 T-cell differentiation stages and survival
HR 95 % CI p values
CD4+ cells
Naïve Model 1 Gender-adjusted 1.02 0.98–1.06 0.26
Model 2 model 1 + CMV 1.02 0.98–1.06 0.26
Model 3 Model 2 + frailty 1.03 0.98–1.08 0.18
Late-differentiated effector memory Model 1 Gender adjusted 1.01 0.99–1.04 0.4
Model 2 Model 1 + CMV 1.01 0.98–1.04 0.36
Model 3 Model 2 + frailty 1 0.98–1.04 0.57
Late-differentiated effector Model 1 Gender adjusted 0.91 0.69–1.2 0.5
Model 2 Model 1 + CMV 0.91 0.69–1.2 0.51
Model 3 Model 2 + frailty 0.85 0.64–1.16 0.31
Differentiation index Model 1 Gender adjusted 1 0.99–1.03 0.45
Model 2 Model 1 + CMV 1 0.99–1.03 0.43
Model 3 Model 2 + frailty 1 0.99–1.04 0.53
CD8+ cells
Naïve Model 1 Gender adjusted 1.14 1.02–1.28 0.025
Model 2 Model 1 + CMV 1.16 1.03–1.3 0.015
Model 3 Model 2 + frailty 1.17 1.02–1.33 0.023
Late-differentiated effector memory Model 1 Gender adjusted 0.98 0.95–1.01 0.18
Model 2 Model 1 + CMV 0.98 0.94–1.01 0.15
Model 3 Model 2 + frailty 0.97 0.94–1.01 0.14
Late-differentiated effector Model 1 Gender adjusted 1.01 0.99–1.03 0.47
Model 2 Model 1 + CMV 1.01 0.99–1.03 0.49
Model 3 Model 2 + frailty 1.01 0.99–1.03 0.61
Differentiation index Model 1 Gender adjusted 1 0.99–1.0 0.54
Model 2 Model 1 + CMV 1 0.99–1.0 0.53
Model 3 Model 2 + frailty 1 0.99–1.0 0.79
Cox regression analysis adjusted for possible confounders
HR hazard ratio, CI confidence interval, CMV cytomegalovirus, frailty activities of daily living, Mini-Mental State Examination,
Geriatric Depression Scale
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with mortality on 2-, 4-, and 6-year follow-up (Wikby et
al. 2005). One interpretation of our findings is that a
decreased level of naïve cells is reciprocated by accu-
mulations of more differentiated effector cell types,
which are cytotoxic and potent cytokine producers,
and crucial for immunosurveillance against previously
encountered infectious agents. Indeed, in the cohort
studied here, the frequency of naïve CD8+ T cells cor-
related significantly with the frequency of late-
differentiated memory T cells, which produce large
amounts of granzyme, perforin, and IFNγ and have high
cytotoxic activity, at least when tested in middle-aged
individuals (Romero et al. 2007). Perhaps, in a modern
society, sessile elderly individuals are more likely to be
challenged by previously encountered rather than novel
pathogens; thus, the higher frequency of effector
memory-type cells would be more beneficial.
Supporting this hypothesis, a strong pro-inflammatory
response after challenge with CMV antigens in vitro in
infected individuals in the absence of an opposing anti-
inflammatory response was associated with better sur-
vival. The ability to mount a pro-inflammatory response
in the absence of an anti-inflammatory response would
also help protect against re-infection with any other
pathogen, conferring a survival benefit. Similarly, in
the larger cohort of the whole Leiden 85-plus Study,
an unopposed pro-inflammatory response of the innate
arm of the immune system in vitro was also associated
Fig. 2 FACS plots demonstrating production of INFγ (upper row), TNF (middle row), and IL-10 (lower row) in the CD3+ gated
population. The unstimulated control (shown in the left-hand panel) was used to set the cut-off for cytokine production
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with better survival (Wijsman et al. 2011). These data
obtained from the individuals at the age of 85 and using
different stimulation and read-out methods further
strengthen our findings here.
Latent infection with CMV is present in the majority
(ca. 85 %) of the elderly (but at 100 % in the IRP group)
in different populations (Crough and Khanna 2009).
Like the other viruses of the Herpes family, CMV can
reactivate in immunocompromised, but also in critically
ill immunocompetent, individuals, and causes severe
disease and death (Cook et al. 1998; Jaber et al. 2005;
Limaye et al. 2008). The strong impact of a latent
infection with this virus on the distribution of the T-
cell phenotypes of the host demonstrated here as well as
in several other studies (Pawelec et al. 2009) reflects the
challenge faced by the immune system in the presence
of this latent infection. Clonal expansions of CD8+ T
cells specific for CMV have been demonstrated in the
elderly in numerous studies (Pawelec et al. 2009).
Interestingly, the number of such clonal expansions
was significantly lower in individuals in the IRP group
compared with individuals in the non-IRP group in the
terminal phase of life (Hadrup et al. 2006). Furthermore,
a limited number of clonal expansions was shown to
correlate with mortality in a small group of CMV-
seropositive nonagenarians (Hadrup et al. 2006), sug-
gesting that decreased immunological control of this
virus might be associated with incipient mortality.
Supporting this notion, in this study using an in vitro
model of CMV reactivation, we have demonstrated that
Fig. 3 Correlation analysis between the in vitro immune response
against immunodominant CMVantigens andmortality in individuals
88 years old at baseline. Kaplan–Meier survival curves for 21 CMV-
seropositive individuals according to response to either pp65 or IE1
(a), or pp65 or IE1 (b) are shown. Donors were grouped according to
the type of cytokine response; only pro-inflammatory—IFNγ, TNF,
and/or IL-17 in the absence of any IL-10 production (black line),
pro-/anti-inflammatory—IL-10 production byCD4+ and/or CD8+T
cells together or in the absence of pro-inflammatory cytokines
(gray line)
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the nature of the anti-CMV response may indeed be
associated with better survival. Ample evidence from
transplant patients suggests a critical role for both pp65-
and IE-1-specific pro-inflammatory T cells (secreting
IFNγ) in controlling viral replication and protecting
from CMV disease (Lacey et al. 2005; Crough et al.
2007; Ganepola et al. 2007; Nebbia et al. 2008). It is not
yet clear if CMV reactivates more frequently in the
elderly and what the clinical implications of a latent
CMV infection are. In one study, CMV DNA could be
detected more frequently in the urine of elderly subjects
but not in the young (Stowe et al. 2007), suggesting
some loss of control of the virus by the immune system
in older people. Reactivation of other herpes viruses,
like Epstein Barr Virus and Varicella Zoster Virus, also
occurs in the elderly (Gilden et al. 2003; Stowe et al.
2007). Even if not directly leading to mortality, in-
creased reactivation of CMV could render the individual
more susceptible to infection with other opportunistic
bacteria as well as contributing to increased low-level
pro-inflammatory status, in itself pathologic in the el-
derly (Crough and Khanna 2009). Accordingly, three
studies have demonstrated a significant correlation be-
tween anti-CMVantibody titers and all-cause as well as
cardiovascular disease-related mortality (Strandberg
et al. 2009; Roberts et al. 2010; Simanek et al. 2011).
Considering the well-documented increased pro-
inflammatory status in the elderly, partly caused by
CMV, and the pathological effects attributed to it
(Franceschi 2007; Sansoni et al. 2008), the survival
benefit of mediating a pro-inflammatory-type response
against CMV observed in our study might seem para-
doxical. It is of note that six of the seven deaths within
the pro-inflammatory responder group were due to car-
diovascular disease or cancer compared to only three of
seven deaths in individuals with an anti-inflammatory
response. Although the number of individuals tested for
cytokine response in our study is too low to draw any
firm conclusions, our data suggest a fine line between
the benefits of having a strong pro-inflammatory re-
sponse, which would allow a better control of infections,
and the negative side effects accompanying it in terms of
inflammation-associated pathologies, such as cardiovas-
cular diseases or cancer.
Numerous studies dating as far back as the 1980s have
repeatedly shown that vaccination with influenza is as-
sociated with a strong reduction in not only pneumonia-
or flu-related but surprisingly also all-cause- as well as
cardiovascular mortality rates (Barker and Mullooly
1980; Nichol et al. 2003, 2007; Campitelli et al. 2010).
In the cohort studied here, 60 % of the deaths occurred
between November throughMarch, the influenza season.
If our findings modeled by CMV do apply to other
memory antigens such as flu, this would translate to
better protection from this disease as well, possibly
explaining the observed survival advantage.
We also observed an inverse correlation between the
frequency of naïve T cells and total CD8+ T cells. Thus,
probably through compensatory homeostatic mecha-
nisms, individuals with a lower frequency of naïve cells
possess more CD8+ Tcells and therefore a larger arsenal
of highly functional EM3 cells. Interestingly, however,
Table 4 Mortality stratified by cytokine response (pro-inflammatory and pro- and anti-inflammatory) to pp65 and IE1 in CMV-
seropositive donors (n018)
Adjusted for gender Adjusted for gender and frailty
HR 95 % CI p value HR 95 % CI p value
Response to pp65 and IE1
Pro-inflammatory response 0.11 0.03–0.48 0.003 0.1 0.02–0.055 0.007
Anti- and pro-inflammatory response 1 (ref) 1 (ref)
Response to pp65
Pro-inflammatory response 0.15 0.03–0.71 0.017 0.18 0.03–0.93 0.041
Anti- and pro–inflammatory response 1 (ref) 1 (ref)
Response to IE1
Pro-inflammatory response 0.15 0.03–0.69 0.015 0.08 0.01–0.72 0.024
Anti- and pro-inflammatory response 1 (ref) 1 (ref)
HR hazard ratio, CI confidence interval, frailty activities of daily living, Mini-Mental State Examination, Geriatric Depression Scale
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the mean frequency of CD8+ T cells in the study pop-
ulation (23.5 %) was similar to the non-IRP group of the
OCTO study at baseline and the 2-year follow-up
(Ferguson et al. 1995; Wikby et al. 1998). Thus, the
expansion of CD8+ T cells was not to a detrimental
degree and did not lead to an inverted CD4/CD8 ratio.
Apart from naïve CD8+ T cells, the frequency of
other T-cell subsets did not have any impact on sur-
vival of the individuals in our study. This is in line
with data from another study limited to women at a
younger age (mean age of 77 years) and using fewer
markers to characterize different T-cell subsets (Semba
et al. 2005). Although in that work a lack of correla-
tion between the frequency of naïve cells and mortal-
ity was reported, these cells were defined simply as
CD45RA+. We now know that CD45RA expression
alone is not sufficient to characterize truly naïve cells,
especially within the CD8 compartment, as a late-
differentiated memory subset re-expresses this isoform
of the leukocyte common antigen phosphatase (Faint
et al. 2001). High numbers of CD8+CD28− T cells,
which was a parameter of the IRP identified in the
OCTO/NONA studies, did not have any impact on 5-
year survival in women over 75 years of age but was
associated with frailty (Semba et al. 2005).
An inverted CD4/CD8 ratio, another parameter of
the IRP, was observed only in one individual (2 %) in
our study, unlike the OCTO and NONA studies, where
14 % of individuals over 85 years of age and 20 % of
individuals older than 90 years had an inverted CD4/
CD8 ratio (Ferguson et al. 1995; Wikby et al. 2002).
The low frequency of individuals with a CD4/CD8
ratio <1 in our cohort might imply the natural selection
of the fittest in the population. Indeed, in a represen-
tative group of the Dutch population at a younger age
(70–81 years, n0100) participating in the Leiden
Longevity Study (data not shown), 20 % of subjects
had a CD4/CD8 ratio <1. We also observed a lower 2-
year mortality (16 %) in the individuals of the Leiden
85-plus Study compared with the OCTO study
(26.5 %), indicating that the elderly studied here do
indeed represent a healthier population, even though
unlike the OCTO study, no exclusion criteria were
applied. In fact, the mortality rate in the population
excluded from the OCTO study was 54 % (Ferguson
et al. 1995). These differences between the populations
studied here, along with the different technical and
statistical platforms applied, could explain the potential
discrepancies observed between our data and those from
the Swedish OCTO/NONA studies. In addition, medical
advances over the intervening 15 years may have con-
tributed to lower mortality in the elderly included in the
Leiden 85-plus study.
Here, we have provided evidence that contrary to
previously accepted models, a reduced frequency of
naive CD8+ T cells, one of the hallmark features of
immunosenescence, may not necessarily be detrimen-
tal for the elderly, at least those aged 88 years and
older participating in the Leiden 85 plus Study. On the
contrary, a lower frequency of naïve T cells, recipro-
cated by an accumulation of late-differentiated effector
memory CD8 T cells, was associated with better sur-
vival. These unexpected findings point to the necessity
of maintaining a delicate balance in the distribution of
different T cells which would ensure a supply of
sufficient effector CD8 cells to combat re-infection
and/or maintain immunosurveillance against chronic
infections, but not to a pathological level. Tipping
this balance towards an inverted CD4/CD8 ratio,
which seems to be irreversible in most individuals,
can have detrimental consequences. This could hap-
pen for example through repeated reactivation of
CMV due to loss of immunological control of the
virus in CMV carriers. Our data demonstrating a
direct correlation between the quality of the immune
response to CMV antigens and mortality support this
hypothesis.
Our findings, although obtained by necessity from
a relatively small group of individuals, are nonetheless
highly statistically significant and provide new
insights into our understanding of the aging human
immune system and its implications for survival and
longevity, as well as eventual interventions to ensure
appropriate functionality of immunity in old age.
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